Day One Biopharmaceuticals, Inc.: key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2025)
- $158.2M
- Net Income/Loss (FY2025)
- -$107.3B
- Total Assets (FY2025)
- $507.8M
- Total Equity (FY2025)
- $441.2M
- Cash Flows from Operating Activities (FY2025)
- -$103.8M
Source: Day One Biopharmaceuticals, Inc. 10-K/A filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
